DYRK1A and Alzheimer disease: In a follow-up study, the authors confirmed these observations and suggested that such reduced interaction between DYRK1A and cytoskeletal proteins may constitute an early biomarker for the diagnosis of Alzheimer’s disease from PMBCs (Dowjat et al., 2019).